Chemotherapy-induced ovarian failure in young women with early breast cancer: Prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials
- 1 July 2021
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 152, 193-203
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Impact of chemotherapy-induced amenorrhea in breast cancer patients: the evaluation of ovarian function by menstrual history and hormonal levelsWorld Journal of Surgical Oncology, 2013
- Menstrual History and Quality-of-Life Outcomes in Women With Node-Positive Breast Cancer Treated With Adjuvant Therapy on the NSABP B-30 TrialJournal of Clinical Oncology, 2011
- Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancerFertility and Sterility, 2010
- Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast CancerNew England Journal of Medicine, 2010
- Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile ageFertility and Sterility, 2010
- Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP SystemJournal of Clinical Oncology, 2007
- Amenorrhea in Premenopausal Women After Adjuvant Chemotherapy for Breast CancerJournal of Clinical Oncology, 2006
- A systematic review of tests predicting ovarian reserve and IVF outcomeHuman Reproduction Update, 2006
- Tamoxifen After Adjuvant Chemotherapy for Premenopausal Women With Lymph Node-Positive Breast Cancer: International Breast Cancer Study Group Trial 13-93Journal of Clinical Oncology, 2006
- Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testingHuman Reproduction Update, 2005